Table 1 ARDS COVID patient’s characteristics at ICU admission
From: Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients
All patients (n = 38) | No Herpesviridae reactivation (n = 20) | Herpesviridae reactivation (n = 18) | P value | |
|---|---|---|---|---|
Demographic characteristics | ||||
Age, years | 59 (54–71) | 57 (48–69) | 64 (55–72) | 0.07 |
Sex | ||||
Men | 27 (71) | 15 (75) | 12 (67) | > 0.99 |
Women | 11 (29) | 5 (25) | 6 (33) | |
BMI | 24 (24–31) | 27 (23–27) | 26.9 (24–29) | 0.78 |
Current smoking | 2 (5) | 1 (5) | 1 (5) | 0.94 |
Coexisting conditions | ||||
Any | 19 (50) | 10 (50) | 9 (50) | > 0.99 |
Diabetes | 15 (40.5) | 7 (35) | 8 (44) | 0.55 |
Cancer | 3 (8) | 2 (10) | 1 (5) | > 0.99 |
Clinical and biological baseline characteristics | ||||
White blood cell count (109/L) | 10.1 (3.4–13) | 7.8 (6–10.4) | 11.2 (7.3–13.2) | 0.07 |
Lymphocyte count (109/L) | 0.74 (0.59–1.04) | 0.79 (0.53–1.06) | 0.83 (0.7–1.23) | 0.29 |
Ratio of PaO2 to FiO2 | 106 (95–170) | 90 (69–142) | 116 (90–147) | 0.15 |
SAPS II score on day 1 | 42 (31–58) | 39 (29–61) | 42 (33–55) | 0.65 |
SOFA score on day 1 | 3 (2–7) | 7 (2–9) | 3 (2–7) | 0.81 |